Anti-angiogenic effects of the fruit of Alpinia oxyphylla

Journal of Ethnopharmacology

Volumn 132, Issue 2, 2010, Pages 443-449

  He, Zhi Heng ^a   Ge, Wei ^a   Yue, Grace Gar Lee ^a   Lau, Clara Bik San ^a   He, Ming Fang ^b   But, Paul Pui Hay ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NANJING TECH UNIVERSITY   (China)

Author keywords

Alpinia oxyphylla; Anti angiogenesis; HUVEC; Zebrafish; Zingiberaceae

Indexed keywords

ALKALINE PHOSPHATASE; ALPINIA OXYPHYLLA EXTRACT; ANGIOGENESIS INHIBITOR; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALPINIA OXYPHYLLA; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EMBRYO; ENZYME ASSAY; FRUIT; HERB; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MEDICINAL PLANT; NONHUMAN; QUANTITATIVE ANALYSIS; WILD TYPE; ZEBRA FISH;

ALPINIA OXYPHYLLA; DANIO RERIO; ZINGIBERACEAE;

EID: 78049374336     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.08.024     Document Type: Article

References (56)

1. Albini A., Tosetti F., Benelli R., Noonan D.M. Tumor inflammatory angiogenesis and its chemoprevention. Cancer Research 2005, 65:10637-10641.
2. Allavena P., Garlanda C., Borrello M.G., Sica A., Mantovani A. Pathways connecting inflammation and cancer. Current Opinion in Genetics and Development 2008, 18:3-10.
3. Ali M.S., Tezuka Y., Awale S., Banskota A.H., Kadota S. Six new diarylheptanoids from the seeds of Alpinia blepharocalyx. Journal of Natural Products 2001, 64:289-293.
4. Ali M.S., Tezuka Y., Banskota A.H., Kadota S. Blepharocalyxins C-E, three new dimeric diarylheptanoids, and related compounds from the seeds of Alpinia blepharocalyx. Journal of Natural Products 2001, 64:491-496.
5. An L.J, Guan S., Shi G.F., Bao Y.M., Duan Y.L., Jiang B. Protocatechuic acid from Alpinia oxyphylla against MPP+-induced neurotoxicity in PC12 cells. Food and Chemical Toxicology 2006, 44:436-443.
6. Ando S., Matsuda H., Morikawa T., Yoshikawa M. 1'S-1'-Acetoxychavicol acetate as a new type inhibitor of interferon-beta production in lipopolysaccharide-activated mouse peritoneal macrophages. Bioorganic and Medicinal Chemistry 2005, 13:3289-3294.
7. Bar J., Onn A. Combined anti-proliferative and anti-angiogenic strategies for cancer. Expert Opinion on Pharmacotherapy 2008, 9:701-715.
8. Bisacchi D., Benelli R., Vanzetto C., Ferrari N., Tosetti F., Albini A. Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives. Cancer Detection and Prevention 2003, 27:229-238.
9. But P.P.H. Alpinia oxyphylla. International Collation of Traditional and Folk Medicine: Northeast Asia. Part II 1997, 202-203. World Scientific, Singapore. P.P.H. But, T. Kimura, J.X. Guo, C.K. Sung (Eds.).
10. Cao Y. Tumor angiogenesis and molecular targets for therapy. Frontiers in Bioscience 2009, 14:3962-3973.
11. Choi J.K., Kim K.M., Kim D.K., Yeom M.H., Koh J.Y., Jung S.J., Kim H.J., Oh S.H., Kim S.Y., Lee C.H. Topical anti-inflammatory and antipruritic effects of Alpinia katsumadai extracts. Journal of Dermatological Science 2009, 53:81-84.
12. Chun K.S., Kang J.Y., Kim O.H., Kang H., Surh Y.J. Effects of yakuchinone A and yakuchinone B on the phorbol ester-induced expression of COX-2 and iNOS and activation of NF-kB in mouse skin. Journal of Environmental Pathology, Toxicology and Oncology 2002, 21:131-139.
13. Chun K.S., Park K.K., Lee J., Kang M., Surh Y.J. Inhibition of mouse skin tumor promotion by anti-inflammatory diarylheptanoids derived from Alpinia oxyphylla Miquel (Zingiberaceae). Oncology Research 2002, 13:37-45.
14. Chun K.S., Sohn Y., Kim H.S., Kim O.H., Park K.K., Lee J.M., Lee J., Lee J.Y., Moon A., Lee S.S., Surh Y.J. Anti-tumor promoting potential of naturally occurring diarylheptanoids structurally related to curcumin. Mutation Research 1999, 428:49-57.
15. Folkman J. Tumor angiogenesis: therapeutic implications. The New England Journal of Medicine 1971, 285:1182-1186.
16. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1995, 1:27-31.
17. Griffioen A.W. Anti-angiogenesis: making the tumor vulnerable to the immune system. Cancer Immunology, Immunotherapy 2008, 57:1553-1558.
18. Hahm E.R., Park S., Yang C.H. 7,8-Dihydroxyflavanone as an inhibitor for Jun-Fos-DNA complex formation and its cytotoxic effect on cultured human cancer cells. Natural Product Research 2003, 17:431-436.
19. He M.F., Huang Y.H., Wu L.W., Ge W., Shaw P.C., But P.P. Triptolide functions as a potent angiogenesis inhibitor. International Journal of Cancer 2010, 126:266-278.
20. He M.F., Liu L., Ge W., Shaw P.C., Jiang R., Wu L.W., But P.P. Antiangiogenic activity of Tripterygium wilfordii and its terpenoids. Journal of Ethnopharmacology 2009, 121:61-68.
21. He Z.H., He M.F., Ma S.C., But P.P. Anti-angiogenic effects of rhubarb and its anthraquinone derivatives. Journal of Ethnopharmacology 2009, 121:313-317.
22. Hua S.Z., Luo J.G., Wang X.B., Wang J.S., Kong L.Y. Two novel monoterpene-chalcone conjugates isolated from the seeds of Alpinia katsumadai. Bioorganic and Medicinal Chemistry Letters 2009, 19:2728-2730.
23. Itokawa H., Watanabe K., Mihashi S. Screening test for antitumor activity of crude drugs (I). Shoyakugaku Zasshi (Japanese Formula) 1979, 33:95-102.
24. Jung H.J., Jeon H.J., Lim E.J., Ahn E.K., Song Y.S., Lee S., Shin K.H., Lim C.J., Park E.H. Anti-angiogenic activity of the methanol extract and its fractions of Ulmus davidiana var. japonica. Journal of Ethnopharmacology 2007, 112:406-409.
25. Kadota S., Tezuka Y., Prasain J.K., Ali M.S., Banskota A.H. Novel diarylheptanoids of Alpinia blepharocalyx. Current Topics in Medicinal Chemistry 2003, 3:203-225.
26. Kobayashi H., Lin P.C. Angiogenesis links chronic inflammation with cancer. Methods in Molecular Biology 2009, 511:185-191.
27. Kong L.Y., Qin M.J., Niwa M. New cytotoxic bis-labdanic diterpenoids from Alpinia calcarata. Planta Medica 2002, 68:813-817.
28. Kuo Y.J., Hsiao P.C., Zhang L.J., Wu M.D., Liang Y.H., Ho H.O., Kuo Y.H. Labdane diterpenoid glycosides from Alpinia densespicata and their nitric oxide inhibitory activities in macrophages. Journal of Natural Products 2009, 72:1097-1101.
29. Lawson N.D., Weinstein B.M. In vivo imaging of embryonic vascular development using transgenic zebrafish. Developmental Biology 2002, 248:307-318.
30. Lee E., Park K.K., Lee J.M., Chun K.S., Kang J.Y., Lee S.S., Surh Y.J. Suppression of mouse skin tumor promotion and induction of apoptosis in HL-60 cells by Alpinia oxyphylla Miquel (Zingiberaceae). Carcinogenesis 1998, 19:1377-1381.
31. Lee J.H., Jung H.S., Giang P.M., Jin X., Lee S., Son P.T., Lee D., Hong Y.S., Lee K., Lee J.J. Blockade of nuclear factor-kappa B signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera. Journal of Pharmacology and Experimental Therapeutics 2006, 316:271-278.
32. Morikawa T, Ando S., Matsuda H., Kataoka S., Muraoka O., Yoshikawa M. Inhibitors of nitric oxide production from the rhizomes of Alpinia galanga: structures of new 8-9' linked neolignans and sesquineolignan. Chemical and Pharmaceutical Bulletin 2005, 53:625-630.
33. Morikawa T., Matsuda H., Toguchida I., Ueda K., Yoshikawa M. Absolute stereostructures of three new sesquiterpenes from the fruit of Alpinia oxyphylla with inhibitory effects on nitric oxide production and degranulation in RBL-2H3 cells. Journal of Natural Products 2002, 65:1468-1474.
34. Muraoka O., Fujimoto M., Tanabe G., Kubo M., Minematsu T., Matsuda H., Morikawa T., Toguchida I., Yoshikawa M. Absolute stereostructures of novel norcadinane- and trinoreudesmane-type sesquiterpenes with nitric oxide production inhibitory activity from Alpinia oxyphylla. Bioorganic and Medicinal Chemistry Letters 2001, 11:2217-2220.
35. Parng C., Seng W.L., Semino C., McGrath P. Zebrafish: a preclinical model for drug screening. Assay and Drug Development Technologies 2002, 1:41-48.
36. Pharmacopoeia Committee Pharmacopoeia of the People's Republic of China 2005, vol. I. Chemical Industry Press, Beijing, pp. 104, 165, 202, 204.
37. Raghunath M., Sy Wong Y., Farooq M., Ge R. Pharmacologically induced angiogenesis in transgenic zebrafish. Biochemical and Biophysical Research Communications 2009, 378:766-771.
38. Ruegg C., Mutter N. Anti-angiogenic therapies in cancer: achievements and open questions. Bulletin du Cancer 2007, 94:753-762.
39. Sartippour M.R., Seeram N.P., Heber D., Hardy M., Norris A., Lu Q., Zhang L., Lu M., Rao J.Y., Brooks M.N. Rabdosia rubescens inhibits breast cancer growth and angiogenesis. International Journal of Oncology 2005, 26:121-127.
40. Sulaiman M.R., Zakaria Z.A., Adilius M., Mohamad A.S., Ismail M., Israf D.A. Antinociceptive and anti-inflammatory effects of the ethanol extract of Alpinia conchigera Griff. leaves in various animal models. Methods and Findings in Experimental and Clinical Pharmacology 2009, 31:241-247.
41. Surh Y.J., Lee E., Lee J.M. Chemoprotective properties of some pungent ingredients present in red pepper and ginger. Mutation Research 1998, 402:259-267.
42. Taraboletti G., Giavazzi R. Modelling approaches for angiogenesis. European Journal of Cancer 2004, 40:881-889.
43. Tewari A., Pant A.K., Mengi N., Patra N.K. A review on Alpinia species: chemical, biocidal and pharmacological aspects. Journal of Medicinal and Aromatic Plant Sciences 1999, 21:1155-1168.
44. Tezuka Y, Gewali M.B., Ali M.S., Banskota A.H., Kadota S. Eleven novel diarylheptanoids and two unusual diarylheptanoid derivatives from the seeds of Alpinia blepharocalyx. Journal of Natural Products 2001, 64:208-213.
45. Tian Z., An N., Zhou B., Xiao P., Kohane I.S., Wu E. Cytotoxic diarylheptanoid induces cell cycle arrest and apoptosis via increasing ATF3 and stabilizing p53 in SH-SY5Y cells. Cancer Chemotherapy and Pharmacology 2009, 63:1131-1139.
46. Tran T.C., Sneed B., Haider J., Blavo D., White A., Aiyejorun T., Baranowski T.C., Rubinstein A.L., Doan T.N., Dingledine R., Sandberg E.M. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer Research 2007, 67:11386-11392.
47. Wang S., Zheng Z., Weng Y., Yu Y., Zhang D., Fan W., Dai R., Hu Z. Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sciences 2004, 74:2467-2478.
48. Westerfield M. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish 1993, University of Oregon Press, Eugene, OR.
49. Xu J., Tan N., Zeng G., Han H., Huang H., Ji C., Zhu M., Zhang Y. Studies on chemical constituents in fruit of Alpinia oxyphylla. China Journal of Chinese Materials Medica 2009, 34:990-993.
50. Yadav P.N., Liu Z., Rafi M.M. A diarylheptanoid from lesser galangal (Alpinia officinarum) inhibits proinflammatory mediators via inhibition of mitogen-activated protein kinase, p44/42, and transcription factor nuclear factor-kappa B. Journal of Pharmacology and Experimental Therapeutics 2003, 305:925-931.
51. Yang H.L, Chen S.C., Chen C.S., Wang S.Y., Hseu Y.C. Alpinia pricei rhizome extracts induce apoptosis of human carcinoma KB cells via a mitochondria-dependent apoptotic pathway. Food and Chemical Toxicology 2008, 46:3318-3324.
52. Yang J., Dai Y., Xia Y.F., Huang W.Z., Wang Z.T. Alpinia katsumadai Hayata prevents mouse sepsis induced by cecal ligation and puncture through promoting bacterial clearance and downregulating systemic inflammation. Phytotherapy Research 2009, 23:267-273.
53. Yu Y.S., Hsu C.L., Yen G.C. Anti-inflammatory effects of the roots of Alpinia pricei Hayata and its phenolic compounds. Journal of Agricultural and Food Chemistry 2009, 57:7673-7680.
54. Yuen J.W., Gohel M.D. Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutrition and Cancer 2005, 53:11-17.
55. Zhang N.N., Bu P., Zhu H.H., Shen W.G. Inhibitory effects of Scutellaria barbata D. Don on tumor angiogenesis and its mechanism. Ai Zheng (Chinese Formula) 2005, 24:1459-1463.
56. Zheng G.Q., Kenney P.M., Lam L.K.T. Potential anticarcinogenic natural products isolated from lemongrass oil and galanga root oil. Journal of Agricultural and Food Chemistry 1993, 41:153-156.